Search Results

There are 29548 results for: content related to: Safety aspects of antiepileptic drugs—focus on pharmacovigilance

  1. Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 9, September 2011, Pages: 964–971, Jonas Bjerring Olesen, Steen Zabell Abildstrøm, Jesper Erdal, Gunnar H. Gislason, Peter Weeke, Charlotte Andersson, Christian Torp-Pedersen and Peter Riis Hansen

    Version of Record online : 18 JUL 2011, DOI: 10.1002/pds.2186

  2. Data sources on drug safety evaluation: a review of recent published meta-analyses

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 1, January 2012, Pages: 21–33, Carlos Alves, Francisco Batel-Marques and Ana Filipa Macedo

    Version of Record online : 25 OCT 2011, DOI: 10.1002/pds.2260

  3. Health care supply and county-level variation in attention-deficit hyperactivity disorder prescription medications

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 442–449, Tim A. Bruckner, Ashley Hodgson, Chris Brown Mahoney, Brent D. Fulton, Peter Levine and Richard M. Scheffler

    Version of Record online : 24 OCT 2011, DOI: 10.1002/pds.2264

  4. Record linkage for pharmacoepidemiological studies in cancer patients

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 1, January 2012, Pages: 94–103, Myrthe P. P. van Herk-Sukel, Valery E. P. P. Lemmens, Lonneke V. van de Poll-Franse, Ron M. C. Herings and Jan Willem W. Coebergh

    Version of Record online : 2 AUG 2011, DOI: 10.1002/pds.2205

  5. Stroke risk and NSAIDs: a systematic review of observational studies

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 12, December 2011, Pages: 1225–1236, Cristina Varas-Lorenzo, Nuria Riera-Guardia, Brian Calingaert, Jordi Castellsague, Antoine Pariente, Lorenza Scotti, Miriam Sturkenboom and Susana Perez-Gutthann

    Version of Record online : 3 OCT 2011, DOI: 10.1002/pds.2227

  6. Comorbidities in an asthma population 8–29 years old: a study from the Norwegian Prescription Database

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 10, October 2012, Pages: 1045–1052, Øystein Karlstad, Per Nafstad, Aage Tverdal, Svetlana Skurtveit and Kari Furu

    Version of Record online : 23 SEP 2011, DOI: 10.1002/pds.2233

  7. Major bleeding risk associated with warfarin and co-medications in the elderly population

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 10, October 2011, Pages: 1057–1063, Agnes I. Vitry, Elizabeth E. Roughead, Emmae N. Ramsay, Adrian K. Preiss, Philip Ryan, Andrew L. Gilbert, Gillian E. Caughey, Sepehr Shakib, Adrian Esterman, Ying Zhang and Robyn A McDermott

    Version of Record online : 17 AUG 2011, DOI: 10.1002/pds.2219

  8. The effect of an educational intervention on meperidine use in Nova Scotia, Canada: a time series analysis

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 2, February 2012, Pages: 177–183, Judith E. Fisher, Ying Zhang, Ingrid Sketris, Grace Johnston and Fred Burge

    Version of Record online : 14 NOV 2011, DOI: 10.1002/pds.2259

  9. Antipsychotic drugs and risk of pulmonary embolism

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 1, January 2012, Pages: 42–48, Benoit Allenet, Sophie Schmidlin, Céline Genty and Jean-Luc Bosson

    Version of Record online : 4 NOV 2011, DOI: 10.1002/pds.2210

  10. Use and costs of oral anticancer agents in the Netherlands in the period 2000–2008

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 10, October 2012, Pages: 1036–1044, Lonneke Timmers, Jan Jacob Beckeringh, Myrthe P. P. van Herk-Sukel, Epie Boven and Jacqueline G. Hugtenburg

    Version of Record online : 29 SEP 2011, DOI: 10.1002/pds.2225

  11. Psychiatric adverse drug reactions reported during a 10-year period in the Swedish pediatric population

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 1, January 2012, Pages: 79–86, Maria Bygdell, Gertrud Brunlöf, Susanna M. Wallerstedt and Jenny M. Kindblom

    Version of Record online : 10 NOV 2011, DOI: 10.1002/pds.2265

  12. Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 10, October 2011, Pages: 1043–1049, Fei-Yuan Hsiao, C. Daniel Mullins, Yu-Wen Wen, Weng-Foung Huang, Pei-Fen Chen and Yi-Wen Tsai

    Version of Record online : 8 AUG 2011, DOI: 10.1002/pds.2202

  13. National changes in oral antipsychotic treatment for people with schizophrenia in primary care between 1998 and 2007 in the United Kingdom

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 2, February 2012, Pages: 161–169, Philip Prah, Irene Petersen, Irwin Nazareth, Kate Walters and David Osborn

    Version of Record online : 19 AUG 2011, DOI: 10.1002/pds.2213

  14. Frequency and determinants of potential drug-drug interactions in an elderly population receiving regular home visits by GPs - results of the home medication review in the AGnES-studies

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 12, December 2011, Pages: 1311–1318, Wolfgang Hoffmann, Neeltje van den Berg, Jochen René Thyrian and Thomas Fiss

    Version of Record online : 15 SEP 2011, DOI: 10.1002/pds.2224

  15. Effectiveness of palivizumab prophylaxis in infants and children in Florida

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 1, January 2012, Pages: 53–60, Almut G. Winterstein, Christian Hampp and Arwa Saidi

    Version of Record online : 15 SEP 2011, DOI: 10.1002/pds.2246

  16. Validation of algorithms to ascertain clinical conditions and medical procedures used during pregnancy

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 11, November 2011, Pages: 1168–1176, Susan E. Andrade, Tiffany A. Moore Simas, Denise Boudreau, Marsha A. Raebel, Sengwee Toh, Beth Syat, Inna Dashevsky and Richard Platt

    Version of Record online : 22 AUG 2011, DOI: 10.1002/pds.2217

  17. Inhaled corticosteroid adherence in paediatric patients: the PACMAN cohort study

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 10, October 2011, Pages: 1064–1072, Ellen S. Koster, Jan A. M. Raaijmakers, Susanne J. H. Vijverberg and Anke-Hilse Maitland-van der Zee

    Version of Record online : 24 AUG 2011, DOI: 10.1002/pds.2228

  18. Few sex differences in the use of drugs for secondary prevention after stroke: a nationwide observational study

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 9, September 2012, Pages: 911–919, Maria Sjölander, Marie Eriksson and Eva-Lotta Glader

    Version of Record online : 8 NOV 2011, DOI: 10.1002/pds.2268

  19. Adherence, therapeutic intensity, and the number of dispensed drugs

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 12, December 2011, Pages: 1255–1261, Bo Hovstadius and Göran Petersson

    Version of Record online : 13 SEP 2011, DOI: 10.1002/pds.2230

  20. Hospitalised ischaemic cerebrovascular accident and risk factors in a primary care database

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 10, October 2011, Pages: 1050–1056, Elisa Martín-Merino, Ana Ruigomez, Saga Johansson and Luis-Alberto García-Rodríguez

    Version of Record online : 8 AUG 2011, DOI: 10.1002/pds.2201